Mativ (MATV) Q2 2026 earnings review
Self-Help Trumps Macro: Massive Beat Against Gloomy Guidance
Mativ delivered a shock to the upside, reporting its strongest financial quarter since its 2022 merger. Just three months ago, management guided for a mid-single-digit Adjusted EBITDA decline in Q2 due to healthcare destocking and input inflation. Instead, Adjusted EBITDA surged 12% YoY to $75.0 million. The company successfully executed aggressive pricing actions to neutralize raw material costs, expanding consolidated EBITDA margins by 130 basis points to 14.1%. Free Cash Flow generation was exceptional at $60.4 million (+24% YoY), funding further debt paydown. While GAAP Net Income technically turned positive at $3.6 million, it was severely suppressed by a massive 47% tax rate and rising interest expenses. Despite these below-the-line drags, the operating turnaround is firmly taking hold.
🐂 Bull Case
Management successfully implemented price hikes to offset what was forecasted to be a $40-$50M annual macro inflation headwind, expanding margins significantly in a soft volume environment.
The company generated $60.4M in Free Cash Flow in the quarter (up 24% YoY), proving that internal working capital discipline is structurally improving the cash profile.
🐻 Bear Case
The Filtration & Advanced Materials (FAM) segment continues to struggle with organic volume declines, relying entirely on pricing to maintain revenue and margin stability.
Despite strong operating income, GAAP net income remains muted by a highly inefficient 47% tax rate and escalating interest expenses on floating-rate debt.
⚖️ Verdict: 🟢
Bullish. Delivering a 12% EBITDA jump when guidance called for a decline is a massive execution win. The internal transformation and pricing agility are clearly capable of overriding external macro challenges.
Key Themes
SAS Segment Margin Breakout
Accelerating. The Sustainable & Adhesive Solutions (SAS) segment was the primary growth engine this quarter. Revenue rose 2.8% to $330.1M, driven by strong performance in Tapes, Labels & Liners. More importantly, proactive pricing easily outpaced manufacturing cost increases, catapulting Adjusted EBITDA by 18.8% and driving margins up 210 basis points to 15.3%.
Pricing Agility Neutralizes Macro Inflation
Stable. In the Q1 call, management warned of a $40-$50M raw material inflation headwind driven by Middle East geopolitical tensions affecting oil derivatives. Q2 results confirm that the January and March pricing actions successfully neutralized this threat. The company is extracting performance-based value from customers rather than just reacting to commodity swings.
FAM Volume Headwinds Persist
Decelerating. Filtration & Advanced Materials (FAM) net sales fell 1.3% (down 0.1% organically) to $201.7M. The decline was driven by lower volume and mix in the Filtration & Netting business, exacerbated by an exited facility. While margin expanded 50 bps to 17.6% via pricing, the inability to drive top-line volume growth in this segment remains a lingering issue.
Rising Interest Expense Contradicts Deleveraging Bull Case
Stable. The prevailing narrative is that Mativ's massive cash flow is rapidly deleveraging the balance sheet. However, despite reducing Net Debt to $908.2M, Q2 interest expense actually rose YoY from $18.6M to $19.3M. This was driven by higher average rates on the floating portion of the debt stack, acting as a direct anchor on bottom-line profitability.
Punitive Tax Structure
Stable. Mativ's Q2 tax rate was an abysmal 47%. The company generated $6.8M in pre-tax income but surrendered $3.2M to taxes. Management attributes this to geographic earnings mix and an inability to offset income with losses in certain jurisdictions due to full valuation allowances. This structural inefficiency materially damages EPS.
Aerospace Specialty Films Commercialization
Accelerating. While not explicitly broken out in the Q2 PR, management teased in Q1 that a sizable new commitment for specialty films from a new aerospace customer would begin commercial shipments in Q2. The 50 bps margin expansion in the FAM segment despite volume drops points to the successful integration of these higher-value, technology-driven applications.
Other KPIs
Accelerating. FCF jumped 24% YoY from $48.9M. Year-to-date operating cash flow reached $68.9M. This exceptional conversion was achieved while intentionally investing $2.6M into working capital to support strategic growth initiatives, proving structural improvements in cash management.
Accelerating. Adjusted EPS jumped significantly from $0.33 in the prior-year period. However, this non-GAAP metric heavily adjusts for $0.25 in purchase accounting expenses and a $0.16 loss on debt extinguishment, showcasing a large delta versus the $0.06 GAAP EPS.
Stable. Down from $953.5 million in Q1 2026 and $934.0 million at the end of 2025. Strong free cash flow is effectively shrinking the principal, though higher floating interest rates continue to pressure servicing costs.
Guidance
Stable. Payable on September 25, 2026. The company maintained its dividend payout, reflecting confidence in its cash flow generation and adequately balancing shareholder returns with its primary goal of debt reduction.
Key Questions
Guidance Delta
In Q1, you guided Q2 EBITDA to be down mid-single digits, yet you delivered a 12% increase. Did the healthcare destocking headwind clear faster than anticipated, or was this entirely driven by earlier-than-expected realization of Wave 2 cost savings?
Floating Rate Exposure
Despite lowering total debt, interest expense increased YoY to $19.3M due to higher floating rates. Following the April refinancing, exactly what percentage of the $974.5M debt stack remains exposed to floating rates?
Tax Optimization
The effective tax rate hit 47% due to stranded jurisdictional losses. Are there specific structural or footprint optimization plans currently underway to better align earnings with utilizable tax jurisdictions?
FAM Volume Recovery
FAM volumes were down due to weakness in Filtration & Netting. Adjusting for the exited facility, what is the organic volume trajectory for this segment heading into the second half of the year?